Marshall Wace’s Zogenix, Inc. ZGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-909,034
| Closed | -$14.8M | – | 4402 |
|
|
2021
Q4 | $14.8M | Sell |
909,034
-1,142,872
| -56% | -$16.7M | 0.03% | 622 |
|
|
2021
Q3 | $31.2M | Sell |
2,051,906
-274,902
| -12% | -$4.29M | 0.13% | 157 |
|
|
2021
Q2 | $40.2M | Buy |
2,326,808
+14,178
| +0.6% | +$261K | 0.18% | 107 |
|
|
2021
Q1 | $45.1M | Sell |
2,312,630
-429,894
| -16% | -$8.82M | 0.21% | 97 |
|
|
2020
Q4 | $54.8M | Buy |
2,742,524
+949,744
| +53% | +$19.4M | 0.3% | 66 |
|
|
2020
Q3 | $32.1M | Buy |
1,792,780
+1,477,891
| +469% | +$36.2M | 0.21% | 111 |
|
|
2020
Q2 | $8.51M | Buy |
314,889
+286,647
| +1,015% | +$7.91M | 0.06% | 331 |
|
|
2020
Q1 | $698K | Buy |
+28,242
| New | +$1.03M | 0.01% | 897 |
|
|
2019
Q4 | – | Sell |
-1,030
| Closed | -$41K | – | 2301 |
|
|
2019
Q3 | $41K | Buy |
+1,030
| New | +$47.5K | ﹤0.01% | 1520 |
|
|
2019
Q2 | – | Sell |
-564,721
| Closed | -$31.1M | – | 2102 |
|
|
2019
Q1 | $31.1M | Buy |
564,721
+430,698
| +321% | +$20.5M | 0.29% | 63 |
|
|
2018
Q4 | $4.89M | Buy |
134,023
+13,356
| +11% | +$547K | 0.05% | 446 |
|
|
2018
Q3 | $5.99M | Buy |
+120,667
| New | +$6.14M | 0.05% | 422 |
|
Marshall Wace's ZGNX Position: Q1 2022 in Review
Marshall Wace sold out of Zogenix, Inc. (ZGNX) in Q1 2022, closing a stake of 909,034 shares — an estimated $14.8M sold.
Marshall Wace first reported a position in ZGNX in Q3 2018 and held it in 12 quarters. The position peaked at $54.8M in Q4 2020. 0 funds tracked by Wall St. Rank hold ZGNX as of Q1 2022.
- Marshall Wace reported no remaining Zogenix, Inc. position as of Q1 2022 after selling out during the quarter.
- Marshall Wace sold 909,034 Zogenix, Inc. shares in Q1 2022, an estimated $14.8M.
- Marshall Wace first reported a position in Zogenix, Inc. in Q3 2018 and held it in 12 quarters.
- Marshall Wace's Zogenix, Inc. position peaked at $54.8M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q1 2022.
Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.